Global CRO Parexel International, headquartered in Waltham, Mass., has acquired privately-owned ClinIntel, a provider of clinical Randomization and Trial Supply Management (RTSM) services, based in Crawley, U.K.

ClinIntel's offerings will be combined into the ClinPhone RTSM suite and are designed to make patient randomization and clinical supply chain solutions more efficient. Capabilities include advanced RTSM technologies for planning, forecasting and supply chain eLogistics. The offerings are particularly helpful in accelerating study start-up timelines. The entire ClinPhone RTSM suite will be available through the Perceptive MyTrials platform and as a standalone solution, and both solutions will be available through the Perceptive Partner Program.

ClinIntel was founded in 2009, and works with biopharmaceutical companies and CROs. The acquisition was funded with existing cash. The business will be integrated into the Parexel Informatics segment.